The effect of flaxseed supplementation on body weight and body composition: a systematic review and meta-analysis of 45 randomized placebo-controlled trials

Obesity Reviews

Volumn 18, Issue 9, 2017, Pages 1096-1107

  Mohammadi Sartang, M ^a   Mazloom, Z ^a   Raeisi Dehkordi, H ^a   Barati Boldaji, R ^a   Bellissimo, N ^b   Totosy de Zepetnek, J O ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RYERSON UNIVERSITY   (Canada)

Author keywords

Body mass index; body weight; flax; obesity

Indexed keywords

BODY MASS; BODY WEIGHT; BODY WEIGHT MANAGEMENT; CONFIDENCE INTERVAL; DIET SUPPLEMENTATION; EFFECT SIZE; FOOD INTAKE; HUMAN; LINSEED; META ANALYSIS; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; BODY COMPOSITION; BODY WEIGHT LOSS; DIETARY SUPPLEMENT; DRUG EFFECTS; FLAX;

PLANT EXTRACT;

BODY COMPOSITION; BODY WEIGHT; DIETARY SUPPLEMENTS; FLAX; HUMANS; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 85021231946     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12550     Document Type: Review

References (94)

1. World Health Organization. Obesity and Overweight. Fact Sheet No 311. Updated March 2013. World Health Organization Available: http://www.who.int/mediacentre/factsheets/fs311/en/index html Accessed. 2013.
2. Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431–1437.
3. Huang H, Chen G, Liao D, Zhu Y, Pu R, Xue X. The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials. Obes Rev 2016; 17: 1329.
4. Baboota RK, Bishnoi M, Ambalam P et al. Functional food ingredients for the management of obesity and associated co-morbidities – a review. J Funct Foods 2013; 5: 997–1012.
5. Hirai S, Takahashi N, Goto T et al. Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies. Mediat Inflamm 2010; 2010.
6. Kovacs E, Mela D. Metabolically active functional food ingredients for weight control. Obes Rev 2006; 7: 59–78.
7. Oomah BD. Flaxseed as a functional food source. J Sci Food Agric 2001; 81: 889–894.
8. Cunnane SC, Ganguli S, Menard C et al. High α-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 1993; 69: 443–453.
9. Covington MB. Omega-3 fatty acids. Atlantica 2004; 1: 2.0.
10. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 2009; 90: 288–297.
11. Bloedon LT, Szapary PO. Flaxseed and cardiovascular risk. Nutr Rev 2004; 62: 18–27.
12. Muir AD. Flax lignans – analytical methods and how they influence our understanding of biological activity. J AOAC Int 2006; 89: 1147–1157.
13. Hall C, Tulbek MC, Xu Y. Flaxseed. Adv Food Nutr Res 2006; 51: 1–97.
14. Adlercreutz H, Fotsis T, Lampe J et al. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography–mass spectrometry. Scand J Clin Lab Invest 1993; 53: 5–18.
15. Ursoniu S, Sahebkar A, Andrica F et al. Effects of flaxseed supplements on blood pressure: a systematic review and meta-analysis of controlled clinical trial. Clin Nutr 2016; 35: 615–625.
16. Bassett CM, Rodriguez-Leyva D, Pierce GN. Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed. Appl Physiol Nutr Metab 2009; 34: 965–974.
17. Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE. Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res 2013; 33: 367–375.
18. de Kleijn MJ, van der Schouw YT, Wilson PW, Grobbee DE, Jacques PF. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal US women: the Framingham study. J Nutr 2002; 132: 276–282.
19. Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A. Flaxseed supplementation in metabolic syndrome management: a pilot randomized, open-labeled, controlled study. Phytother Res 2016; 30: 1339–1344.
20. Brant LHC, LFMdF C, Velarde LGC, Boaventura GT. Impact of flaxseed intake upon metabolic syndrome indicators in female Wistar rats. Acta Cir Bras 2012; 27: 537–543.
21. Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study. Int J Food Sci Nutr 2016; 67: 461–469.
22. Taylor CG, Noto AD, Stringer DM, Froese S, Malcolmson L. Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 2010; 29: 72–80.
23. Barceló-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr 2008; 88: 801–809.
24. Faintuch J, Bortolotto LA, Marques PC, Faintuch JJ, França JI, Cecconello I. Systemic inflammation and carotid diameter in obese patients: pilot comparative study with flaxseed powder and cassava powder. Nutr Hosp 2011; 26: 208–213.
25. Khalatbari Soltani S, Jamaluddin R, Tabibi H et al. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodial Int 2013; 17: 275–281.
26. Moher D, Shamseer L, Clarke M et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1.
27. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12.
28. Moher D, Cook D, Jadad A et al. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (Winch Eng) 1999; 3: i.
29. Zheng JS, Lin M, Fang L et al. Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: a double-blind randomized controlled trial. Mol Nutr Food Res 2016; 60: 2176–2184.
30. McManus RM, Jumpson J, Finegood DT, Clandinin MT, Ryan EA. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 1996; 19: 463–467.
31. Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism 2011; 60: 1711–1718.
32. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Wiley Online Library, 2008.
33. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
34. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2014; 28: 633–642.
35. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–463.
36. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta-Analysis version 2, Vol. 104. Biostat: Englewood, NJ, 2005.
37. Almario RU, Karakas SE. Lignan content of the flaxseed influences its biological effects in healthy men and women. J Am Coll Nutr 2013; 32: 194–199.
38. Arjmandi BH, Khan DA, Juma S et al. Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. Nutr Res 1998; 18: 1203–1214.
39. Avelino APA, Oliveira GMM, Ferreira CCD, Luiz RR, Rosa G. Additive effect of linseed oil supplementation on the lipid profiles of older adults. Clin Interv Aging 2015; 10: 1679–1685.
40. Barden AE, Croft KD, Durand T, Guy A, Mueller MJ, Mori TA. Flaxseed oil supplementation increases plasma F1-phytoprostanes in healthy men. J Nutr 2009; 139: 1890–1895.
41. Barre DE, Mizier-Barre KA, Stelmach E et al. Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis – an invitation to further investigation into polypharmacy reduction. J Nutr Metab 2012; 585170: 7.
42. Blackwood DP, LaVallée RK, Al Busaidi A, Jassal DS, Pierce GN. A randomized trial of the effects of ezetimibe on the absorption of omega-fatty acids in cardiac disease patients: a pilot study. Clin Nutr ESPEN 2015; 10: 155–159.
43. Brooks JD, Ward WE, Lewis JE et al. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 2004; 79: 318–325.
44. Cassani RSL, Fassini PG, Silvah JH, Lima CMM, Marchini JS. Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study. Nutr J 2015; 14: 5.
45. Colli MC, Bracht A, Soares AA et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. J Med Food 2012; 15: 840–845.
46. Demark-Wahnefried W, Polascik TJ, George SL et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates on men presurgery. Cancer Epidemiol Biomark Prev 2008; 17: 3577–3587.
47. Dittrich M, Jahreis G, Bothor K et al. Benefits of foods supplemented with vegetable oils rich in alpha-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail. Eur J Nutr 2015; 54: 881–893.
48. Dodin S, Lemay A, Jacques H, Légaré F, Forest JC, Mâsse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005; 90: 1390–1397.
49. Faintuch J, Horie LM, Barbeiro HV et al. Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid. Obes Surg 2007; 17: 341–347.
50. Gillingham LG, Robinson KS, Jones PJH. Effect of high-oleic canola and flaxseed oils on energy expenditure and body composition in hypercholesterolemic subjects. Metabolism 2012; 6: 1598–1605.
51. Hallund J, Ravn-Haren G, Bügel S, Tholstrup T, Tetens I. A lignan complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmenopausal women. J Nutr 2006; 136: 112–116.
52. Jenkins DJA, Kendall CWC, Vidgen E et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. A Am J Clin Nutr 1999; 69: 395–402.
53. Katare C, Saxena S. Amelioration of selected cardiac risk factors through supplementation of diet with flaxseed and soya bean. Int J Nutr Pharmacol Neurol Dis 2013; 3: 352.
54. Kawakami Y, Yamanaka-Okumura H, Naniwa-Kuroki Y, Sakuma M, Taketani Y, Takeda E. Flaxseed oil intake reduces serum small dense low-density lipoprotein concentrations in Japanese men: a randomized, double blind, crossover study. Nutr J 2015; 14: 39.
55. Kontogianni MD, Vlassopoulos A, Gatzieva A et al. Flaxseed oil does not affect inflammatory markers and lipid profile compared to olive oil, in young, healthy, normal weight adults. Metabolism 2013; 62: 686–693.
56. Li D, Sinclair A, Wilson A et al. Effect of dietary α-linolenic acid on thrombotic risk factors in vegetarian men. Am J Clin Nutr 1999; 69: 872–882.
57. Lucas EA, Wild RD, Hammond LJ et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002; 87: 1527–1532.
58. Mandaşescu S, Mocanu V, Dăscaliţa A et al. Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 2004; 109: 502–506.
59. Mirfatahi M, Tabibi H, Nasrollahi A, Hedayati M, Taghizadeh M. Effect of flaxseed oil on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients: a randomized controlled trial. Int J Nephrol Urol 2016; 48: 1335–1341.
60. Nelson TL, Hokanson JE, Hickey MS. Omega-3 fatty acids and lipoprotein associated phospholipase A2 in healthy older adult males and females. Eur J Nutr 2011; 50: 185–193.
61. Nelson TL, Stevens JR, Hickey MS. Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults. Metabolism 2007; 56: 1209–1215.
62. Pan A, Sun J, Chen Y et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One 2007; 2 e1148.
63. Pang D, Allman-Farinelli M, Wong T, Barnes R, Kingham K. Replacement of linoleic acid with α-linolenic acid does not alter blood lipids in normolipidaemic men. Br J Nutr 1998; 80: 163–167.
64. Paschos GK, Zampelas A, Panagiotakos DB et al. Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. Eur J Nutr 2007; 46: 315–320.
65. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003; 167: 237–242.
66. Rhee Y, Brunt A. Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design. Nutr J 2011; 10: 44.
67. Rodriguez-Leyva D, Weighell W, Edel AL et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 2013; 62: 1081–1089.
68. Saxena S, Katare C. Evaluation of flaxseed formulation as a potential therapeutic agent in mitigation of dyslipidemia. Biom J 2014; 37: 386–390.
69. Soleimani A, Taghizadeh M, Bahmani F, Badroj N, Asemi Z. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Clin Nutr 2015; 10: 1–6.
70. Tint D, Anghel M, Lupu D, Fischer L, Niculescu M. Low dose flaxseed oil supplementation alters the fatty acids profile and the progression of metabolic syndrome in men without adequate medical treatment. J Nutr Disord Ther 2011; S7.
71. Torkan M, Hassan Entezari M, Siavash M. Effect of flaxseed on blood lipid level in hyperlipidemic patients. Rev Recent Clin Trials 2015; 10: 61–67.
72. Wu H, Pan A, Yu Z et al. Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr 2010; 140: 1937–1942.
73. Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A. Flaxseed supplementation in metabolic syndrome management: a pilot randomized, open-labeled, controlled study. Phytother Res 2016; 30: 1339–1344.
74. Mantzioris E, James MJ, Gibson RA, Cleland LG. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 1994; 59: 1304–1309.
75. Karakas SE, Perroud B, Kind T, Palazoglu M, Fiehn O. Changes in plasma metabolites and glucose homeostasis during omega-3 polyunsaturated fatty acid supplementation in women with polycystic ovary syndrome. BBA Clinical 2016; 5: 179–185.
76. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191–1201.
77. Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M. Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 2008; 100: 669–676.
78. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999; 99: 1355–1362.
79. Thompson LU, Cunnane SC. Flaxseed in Human Nutrition. AOCS Press, 2003.
80. Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev 2001; 59: 129–139.
81. Kristensen M, Jensen MG. Dietary fibres in the regulation of appetite and food intake. Importance of viscosity Appetite 2011; 56: 65–70.
82. Sleeth ML, Thompson EL, Ford HE, Zac-Varghese SE, Frost G. Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr Res Rev 2010; 23: 135–145.
83. Kristensen M, Jensen MG, Aarestrup J et al. Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion, but magnitude of effect depend on food type. Nutr Metab 2012; 9: 1.
84. Theuwissen E, Mensink RP. Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 2008; 94: 285–292.
85. Burdge G. α-Linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 2004; 7: 137–144.
86. Garaulet M, Hernández-Morante J, Tébar F, Zamora S. Anthropometric indexes for visceral fat estimation in overweight/obese women attending to age and menopausal status. J Physiol Biochem 2006; 62: 245–252.
87. Buckley JD, Howe P. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev 2009; 10: 648–659.
88. Buckley JD, Howe PR. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity – a review. Nutrients 2010; 2: 1212–1230.
89. Wien M, Rajaram S, Oda K, Sabaté J. Decreasing the linoleic acid to α-linolenic acid diet ratio increases eicosapentaenoic acid in erythrocytes in adults. Lipids 2010; 45: 683–692.
90. Kuo S-M. The interplay between fiber and the intestinal microbiome in the inflammatory response. Adv Nutr: An Intern Rev J 2013; 4: 16–28.
91. Muir A, Westcott N, Ballantyne K, Northrup S. Flax lignans: recent developments in the analysis of lignans in plant and animal tissues. Proc Flax Inst of the USA 2000; 58: 23–32.
92. Setchell K, Adlercreutz H. Mammalian lignans and phyto-oestrogens recent studies on their formation, metabolism and biological role in health and role of the gut flora in toxicity and cancer. 1988; 315.
93. Horner NK, Kristal AR, Prunty J, Skor HE, Potter JD, Lampe JW. Dietary determinants of plasma enterolactone. Cancer Epidemiol Biomark Prev 2002; 11: 121–126.
94. Morisset A-S, Lemieux S, Veilleux A, Bergeron J, Weisnagel SJ, Tchernof A. Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr 2009; 102: 195–200.